2026 NPPES data Medical Oncology Physician NPI 1902868789 MD
Verify on CMS →

RODERICK PARAS, MD

Medical Oncology Physician in ORANGE CITY, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
217
Medicare Part D claims · 67 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$127.88
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RODERICK PARAS, MD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 217 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
217
Part D claims, 2023
75%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RODERICK PARAS, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RODERICK PARAS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RODERICK PARAS, MD?

High performer (top quartile)

NPI registry status

Active

Issued 04/05/2006

NPI 1902868789

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

217 69% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Medical Oncology Physician compares to other specialties among Florida providers

Florida providers

Medical Oncology Physician share within Florida

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Florida

Medicare quality performance — MIPS

RODERICK PARAS, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RODERICK PARAS, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 2824 ENTERPRISE RD, ORANGE CITY, FL, 32763, with a listed phone of (386) 774-7411. NPI 1902868789 was issued on 04/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PARAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 217 prescription claims written by this provider, covering 67 Medicare beneficiaries and totaling roughly $447K in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 5.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 95.3636, Cost 97.0724), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2824 ENTERPRISE RD
ORANGE CITY, FL 32763

Provider Details

NPI 1902868789
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 04/05/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
95.3636
Quality
97.0724
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where RODERICK PARAS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
ORANGE CITY, FL
GUAM HEALTHCARE DEVELOPMENT INCORPORATED
DEDEDO, GU

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RODERICK PARAS, MD. Source: openpaymentsdata.cms.gov.

Total received

$128

Largest payer

Tempus AI, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to RODERICK PARAS, MD. To verify RODERICK PARAS, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RODERICK PARAS, MD — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 217 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

217
Total Claims
$447K
Total Drug Cost
67
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
276
Total Day Supply
7,197
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$434K
Generic Drug Cost
$13K
Opioid Claims
12 (5.5% rate)

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
2.19
Gender Split
60% female / 40% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RODERICK PARAS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Xtandi
Enzalutamide
20
Letrozole
14
Eliquis
Apixaban
13
Ondansetron Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How RODERICK PARAS, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

RODERICK PARAS, MD's 217 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as PARAS.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RODERICK PARAS, MD's specialty?
RODERICK PARAS, MD specializes in Medical Oncology Physician and practices in ORANGE CITY, Florida. Credentials: MD.
How much does RODERICK PARAS, MD prescribe under Medicare Part D?
In 2023, RODERICK PARAS, MD wrote 217 Medicare Part D claims totaling $447K in drug costs for 67 beneficiaries.
What is RODERICK PARAS, MD's Medicare quality score?
RODERICK PARAS, MD has a CMS MIPS Final Score of 100/100 (Quality: 95.3636, Cost: 97.0724). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RODERICK PARAS, MD located?
RODERICK PARAS, MD is located at 2824 ENTERPRISE RD, ORANGE CITY, FL, 32763. Phone: (386) 774-7411.
What is RODERICK PARAS, MD's NPI number?
RODERICK PARAS, MD's National Provider Identifier (NPI) is 1902868789, issued on 04/05/2006.
Does RODERICK PARAS, MD prescribe more brand-name or generic drugs?
RODERICK PARAS, MD's prescribing is 25% brand-name and 75% generic drugs by claim count, with $434K in brand drug costs.
Does RODERICK PARAS, MD prescribe opioids?
Yes, RODERICK PARAS, MD had 12 opioid claims in 2023 with an opioid prescribing rate of 5.5%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does RODERICK PARAS, MD prescribe most often?
Based on 2023 Medicare Part D data, RODERICK PARAS, MD's most frequently prescribed drugs include Xtandi, Letrozole, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RODERICK PARAS, MD accept Medicare?
RODERICK PARAS, MD appears in CMS Medicare data with 217 Part D claims and 67 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RODERICK PARAS, MD's credentials?
RODERICK PARAS, MD's NPI is 1902868789 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology